Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DOV 21: Phase II start

In 1Q08, DOV will begin a double-blind, dose-escalation

Read the full 80 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE